Delforge Marie-Luce, Costa Elena, Brancart Françoise, Goldman Deborah, Montesinos Isabel, Zaytouni Siham, Marchant Arnaud, Donner Catherine
Department of Microbiology, Hôpital Universitaire Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Department of Obstetrics and Gynecology, Hôpital Universitaire Erasme, Université Libre de Bruxelles, Brussels, Belgium.
J Clin Virol. 2017 May;90:14-17. doi: 10.1016/j.jcv.2017.03.004. Epub 2017 Mar 7.
Cytomegalovirus (CMV) congenital infection can result from primary infection, reinfection or reactivation among pregnant women. The risk of vertical transmission is much higher in case of primary infection, and the transmission rate increases with gestational age. However there are still many questions about maternal markers that can predict whether the virus will be transmitted to the fetus.
To investigate the relationship between the presence and the quantity of CMV in urine and blood of women presenting a primary CMV infection during pregnancy and the presence of congenital infection in their offspring.
Detection and quantification of CMV DNA was performed on 150 urine samples and 114 blood samples from 150 pregnant women with proven CMV primary infection.
Transmission rate was 36.7% (55/150). A statistically significant association was found between the presence of CMV in maternal urine and newborn infection (OR 2.03 95%CI 1.03-3.99). A clearly significant association was found between the presence of CMV in maternal blood and newborn infection (OR 3.14 95% CI 1.38-7.16). Taking into consideration those samples that are positive for CMV in maternal urine, the median value of viral load was significantly higher in those patients who transmitted to offspring (P=0.015). No significant association between viral load in maternal blood and newborn infection was observed.
The presence of CMV in maternal urine and maternal blood correlated to the transmission of CMV to offspring in our cohort. The median viral load in urine is higher in women who transmitted. These markers may help to identify pregnant women at risk to transmit to the fetus.
巨细胞病毒(CMV)先天性感染可由孕妇的原发性感染、再感染或病毒再激活引起。原发性感染时垂直传播的风险要高得多,且传播率随孕周增加而升高。然而,关于能够预测病毒是否会传播给胎儿的母体标志物仍存在许多问题。
研究孕期原发性巨细胞病毒感染女性尿液和血液中巨细胞病毒的存在及数量与子代先天性感染之间的关系。
对150例确诊为原发性巨细胞病毒感染的孕妇的150份尿液样本和114份血液样本进行巨细胞病毒DNA的检测和定量分析。
传播率为36.7%(55/150)。发现母体尿液中存在巨细胞病毒与新生儿感染之间存在统计学显著关联(比值比2.03,95%置信区间1.03 - 3.99)。发现母体血液中存在巨细胞病毒与新生儿感染之间存在明显显著关联(比值比3.14,95%置信区间1.38 - 7.16)。考虑到母体尿液中巨细胞病毒呈阳性的样本,病毒载量中位数在传播给子代的患者中显著更高(P = 0.015)。未观察到母体血液中病毒载量与新生儿感染之间存在显著关联。
在我们的队列中,母体尿液和血液中巨细胞病毒的存在与巨细胞病毒传播给子代相关。传播的女性尿液中的病毒载量中位数更高。这些标志物可能有助于识别有传播给胎儿风险的孕妇。